A SPRINT to the finish, or just the beginning? Implications of the SPRINT results for nephrologists.
rct · Level II
Where this comes from
- Record sourced from PubMed, PMID 26806825.
- Also identified by DOI 10.1016/j.kint.2015.12.024.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The Systolic Blood Pressure Intervention Trial (SPRINT) demonstrated a significant reduction in major cardiovascular events and all-cause mortality with intensive blood pressure control in older individuals at high cardiovascular risk, including patients with chronic kidney disease and mild proteinuria. Nephrologists should consider the SPRINT results when determining the optimal blood pressure target for patients with chronic kidney disease.
Medical subject headings
- Antihypertensive Agents
- Hypertension
- Nephrology